| Line item | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | -$267.30K |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | $31.49K |
| Operating Income | – | $2.20M | – | – | – |
| Interest Expense | – | – | – | – | $79.04K |
| Tax Expense | – | – | – | – | – |
| Net Income | – | – | – | – | -$159.25K |
| EPS (basic) | -0.0300 | – | -0.0300 | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $28.47M | $18.29M | $53.91M | $45.19M | – |